Published in Ann Rheum Dis on November 01, 2001
HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum (2009) 2.00
'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease. Nat Rev Rheumatol (2015) 1.99
Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations. Clin Rheumatol (2010) 1.77
Mimicry and deception in inflammatory bowel disease and intestinal behçet disease. Gastroenterol Hepatol (N Y) (2012) 1.11
Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (2014) 1.07
Biological treatments in Behçet's disease: beyond anti-TNF therapy. Mediators Inflamm (2014) 1.07
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Yonsei Med J (2016) 1.03
Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int (2007) 1.03
Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Clin Exp Immunol (2005) 1.01
Potential Infectious Etiology of Behçet's Disease. Patholog Res Int (2011) 0.94
Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin Med Res (2006) 0.94
Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum Immunol (2006) 0.91
Role of polymorphisms in Adamantiades-Behçet's disease. J Rheumatol (2008) 0.91
Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol (2002) 0.88
T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease. Clin Rheumatol (2007) 0.87
Pro-inflammatory cellular immune response in Behçet's disease. Rheumatol Int (2007) 0.87
Differential diagnosis and management of Behçet syndrome. Nat Rev Rheumatol (2012) 0.86
Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol Vis (2008) 0.85
High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Haematologica (2016) 0.85
Similarities and differences between Behçet's disease and Crohn's disease. World J Gastrointest Pathophysiol (2014) 0.83
Association Analysis of IL10, TNF-α, and IL23R-IL12RB2 SNPs with Behçet's Disease Risk in Western Algeria. Front Immunol (2013) 0.83
Immunopathogenesis of ocular Behçet's disease. J Immunol Res (2014) 0.83
Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet's disease. Rheumatol Int (2005) 0.82
Cardiac manifestations in Behcet's disease. Intractable Rare Dis Res (2015) 0.82
Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease. Genet Res Int (2013) 0.81
Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm (2004) 0.81
Extracellular high-mobility group box 1 is increased in patients with Behçet's disease with intestinal involvement. J Korean Med Sci (2011) 0.81
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease. Medicine (Baltimore) (2015) 0.81
[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?]. Ophthalmologe (2012) 0.80
Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease. Arthritis Res Ther (2008) 0.79
Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. Clin Rheumatol (2007) 0.79
Targeted resequencing of candidate genes reveals novel variants associated with severe Behçet's uveitis. Exp Mol Med (2013) 0.79
Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis. Mol Vis (2013) 0.78
Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Clin Exp Immunol (2016) 0.78
Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease. Rheumatol Int (2003) 0.78
Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease. Arthritis Res Ther (2013) 0.78
The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease. Noro Psikiyatr Ars (2014) 0.78
Behcet's disease: systemic and ocular manifestations. Biomed Res Int (2013) 0.77
Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease. Autoimmune Dis (2013) 0.77
Behçet syndrome: from pathogenesis to novel therapies. Clin Exp Med (2014) 0.77
Genetic susceptibility to Behçet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol Int (2008) 0.76
Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014. Orphanet J Rare Dis (2014) 0.76
Mandibular bone mineral density in patients with Behçet's disease. Ther Clin Risk Manag (2015) 0.75
Polymorphisms of Promoter Region of TNF-α Gene in Iranian Azeri Turkish Patients with Behçet's Disease. J Korean Med Sci (2017) 0.75
Intestinal Behçet and Crohn's disease: two sides of the same coin. Pediatr Rheumatol Online J (2017) 0.75
Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study. PLoS One (2016) 0.75
Persistent fever, neck swelling, and small vessel vasculitis following tonsillectomy in a patient with Behçet's disease: a case report. J Med Case Rep (2012) 0.75
The great masquerader: Behcet's disease. BMJ Case Rep (2014) 0.75
Demographical and Clinical Characteristics of Behcet's Disease in Southeastern Turkey. J Clin Med Res (2014) 0.75
The Evaluation of Saliva Flow Rate, pH, Buffer Capacity, Microbiological Content and Indice of Decayed, Missing and Filled Teeth in Behçet's Patients. Balkan Med J (2013) 0.75
miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease. Sci Rep (2016) 0.75
Serum ghrelin levels in patients with Behcet's disease. Postepy Dermatol Alergol (2016) 0.75
Effective Treatment of Intestinal Behçet's Disease with Long-Term, Low-Dose Clarithromycin. Case Rep Gastroenterol (2013) 0.75
Elevated serum chemokine levels in Behçet's disease with uveitis. Rheumatol Int (2003) 0.75
Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis. Clin Rheumatol (2013) 0.75
[Ocular Behçet]. Pan Afr Med J (2017) 0.75
Nasal Staphylococcus aureus carriage is not increased in Behçet's disease. Rheumatol Int (2005) 0.75
Serum Profiles of Cytokines in Behcet's Disease. J Clin Med (2017) 0.75
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Behçet's disease. N Engl J Med (1999) 7.74
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med (1993) 4.99
The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol (1953) 2.97
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.78
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial. Arthritis Rheum (1996) 1.72
The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol (1977) 1.69
Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today (1996) 1.60
Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today (1995) 1.51
Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45
Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol (2001) 1.41
T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol (1993) 1.37
Vasculitis in Behçet's disease. Int Rev Immunol (1997) 1.36
Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol (1990) 1.35
The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol (1997) 1.32
Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol (1998) 1.29
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum (1999) 1.27
Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis (2000) 1.27
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol (1999) 1.26
Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum (1995) 1.21
The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol (1988) 1.21
Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol (1997) 1.18
Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci (1998) 1.17
Pathogenic gene responsible for the predisposition of Behçet's disease. Int Rev Immunol (1997) 1.13
Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today (1998) 1.12
Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. J Rheumatol (1992) 1.10
Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol (1993) 1.10
T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol (2000) 1.09
Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol (1999) 1.08
Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. Int Immunol (1995) 1.04
Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest (1995) 1.04
Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology (Oxford) (1999) 1.02
Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum (2001) 1.01
The ten-year mortality in Behçet's syndrome. Br J Rheumatol (1996) 1.01
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol (1999) 1.00
Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol (1999) 0.98
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol (1996) 0.98
Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol (1997) 0.97
Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol (1995) 0.97
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum (1999) 0.96
The immunologic homunculus in rheumatoid arthritis. Arthritis Rheum (1999) 0.95
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease. Cell Immunol (1992) 0.95
Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol (1994) 0.95
Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum (1986) 0.95
Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum (1984) 0.94
Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients. Clin Exp Immunol (1998) 0.94
The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol (1997) 0.92
Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol (2000) 0.92
Oligoclonal T cell expansions in patients with Behçet's disease. Clin Exp Immunol (1999) 0.92
Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm (1999) 0.92
T cell recognition of stress proteins. A link between infectious and autoimmune disease. Mol Biol Med (1990) 0.89
Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis (1996) 0.89
Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies. Clin Exp Immunol (1998) 0.87
Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis. Clin Exp Rheumatol (1988) 0.87
Anticardiolipin antibodies in Behçet's disease: a reassessment. Rheumatology (Oxford) (2001) 0.87
Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol (2000) 0.85
Expression of Th2 cytokines decreases the development of and improves Behçet's disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis (2001) 0.84
Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets. J Rheumatol (1999) 0.83
Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol Lett (1999) 0.83
Neutrophil chemotaxis in Behçet's syndrome. Ann Rheum Dis (1999) 0.82
Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease. J Rheumatol (1999) 0.81
Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease--effects of colchicine. Clin Exp Rheumatol (1991) 0.81
Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol (1997) 0.81
Immunogenetic studies of Behçet's disease. Rev Rhum Engl Ed (1997) 0.80
Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis. Eur J Immunol (1994) 0.79
Behçet disease and the emergence of thalidomide. Ann Intern Med (1998) 0.78